Leah Kuntz

The first and only treatment to use proprietary precision olfactory delivery technology to deliver DHE to the upper nasal cavity just received FDA approval.

6 frontline physician groups expressed their concern about the Texas state law that bans abortions after 6 weeks of pregnancy.

The one-of-its-kind 6-month paliperidone palmitate treatment for schizophrenia has received FDA approval.

According to the CDC, construction workers commit suicide 4 times more than the general population. What can be done to stem this hazard?

Mental health care for US service members, refugees, and Afghans will be crucial.

What toll does trauma take on police officers, firefighters, and EMT workers?

First of its kind study found aggression in US couples saw a 6- to 8-fold increase during the pandemic.

The National Correctional Health Care Conference is back and ready to deliver the latest on correctional and public health.

A kappa-opioid receptor with psychedelic effects, this potential agent for treatment-resistant depression and other disorders will be paired with a digital therapeutic for maximum efficacy.

This hypersomnia treatment just received an extended approval for cataplexy and excessive daytime sleepiness.

A new study finds amyloid plaques accelerate the breakup of neurotransmitters, worsening neurodegenerative diseases like Alzheimer disease.

The documentary Orchestrating Change has won the 2021 Austen Riggs Erikson Prize for Excellence in Mental Health Media.

More potential good news for treating Alzheimer disease, as an 18-month open-label extension for lecanemab allows for its breakthrough status.

An extended release, ultra-long acting antipsychotic takes another step forward in the approval process.

After the largest increase in overdose deaths in 50 years, the American Psychiatric Association sends out the call for improved substance use care.

If approved, SLS-002 would be only the second approved product for ASIB.

New research may help better understand psychosis etiology as well as provide potential biomarkers for psychosis.

Novel digital therapy modia will be evaluated in combination with sublingual buprenorphine/naloxone background therapy to see whether it is superior in reducing opioid use.

To combat drug overdoses, the Rhode Island governor signed a bill allowing people to consume pre-obtained drugs under safe, professional supervision of trained staff.

Following criticism for its wide-labeled June approval, the FDA has decided to narrow the patient recommendation for aducanumab.

Donanemab for the treatment of Alzheimer disease has received Breakthrough Therapy designation from the FDA.

For the first time since 2015, Scottish Parliament is considering legislation on medical aid in dying.

The 2021 American Psychiatric Association Virtual Annual Meeting brought together leaders in psychiatry to discuss hot topics including diversity, COVID-19, mood disorders, and more.

According to a recent study, COVID-19 vaccines did not impact sperm parameters.

Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office.

Genes may hold the answer to the puzzling comorbidity of migraines and posttraumatic stress disorder.

These deals can help boost you and your patients’ mental health.

Zuranolone showed statistically significant improvement in depressive symptoms in this latest study.

This renowned psychiatrist is donating a portion of the proceeds from his book sales to help stop US military veteran suicides.

The Drug Policy Reform Act, introduced today, intends to decriminalize drug use and possession, providing health-centered approaches and rehabilitation instead.